{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:14:02Z","timestamp":1790374442873,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":629,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.yebeh.2011.08.005","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T09:49:32Z","timestamp":1315734572000},"page":"511-517","source":"Crossref","is-referenced-by-count":38,"title":["Are adverse effects of antiepileptic drugs different in symptomatic partial and idiopathic generalized epilepsies? The Portuguese\u2013Brazilian validation of the Liverpool Adverse Events Profile"],"prefix":"10.1016","volume":"22","author":[{"given":"H.H.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.B.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vidal-Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.D.","family":"Carbonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"de Ara\u00fajo Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.O.","family":"Caboclo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Yacubian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Guilhoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2011.08.005_bb0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1528-1157.1997.tb01128.x","article-title":"Quality of life of people with epilepsy: a European study","volume":"38","author":"Baker","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0010","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM199209103271104","article-title":"A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic\u2013clonic seizures in adults","volume":"327","author":"Mattson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM198507183130303","article-title":"Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic\u2013clonic seizures","volume":"313","author":"Mattson","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.62.1.23","article-title":"Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial","volume":"62","author":"Gilliam","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0025","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1212\/01.wnl.0000296051.34044.07","article-title":"Seizure medications and their side effects","volume":"69","author":"Karceski","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2011.08.005_bb0030","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1212\/WNL.58.8_suppl_5.S9","article-title":"Optimizing health outcomes in active epilepsy","volume":"58","author":"Gilliam","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.yebeh.2003.08.033","article-title":"Lamotrigine monotherapy compared with carbamazepine, phenytoin or valproate monotherapy in patients with epilepsy","volume":"4","author":"Kaminow","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 6","key":"10.1016\/j.yebeh.2011.08.005_bb0040","first-page":"S18","article-title":"Development of a patient-based symptom check list to quantify adverse events in persons receiving antiepileptic drugs","volume":"34","author":"Baker","year":"1993","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2011.08.005_bb0045","first-page":"S59","article-title":"The Liverpool Adverse Drug Events Profile","volume":"36","author":"Baker","year":"1995","journal-title":"Epilepsia"},{"issue":"Suppl. 7","key":"10.1016\/j.yebeh.2011.08.005_bb0050","first-page":"S80","article-title":"Initial development, reliability, and validity of a patient-based adverse event scale","volume":"35","author":"Baker","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1528-1157.1998.tb01361.x","article-title":"Commission on outcome measurement in epilepsy, 1994\u20131997: final report","volume":"39","author":"Baker","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1528-1167.2006.00956.x","article-title":"The Liverpool Adverse Events Profile: relation to AED use and mood","volume":"48","author":"Panelli","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0065","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.yebeh.2008.11.016","article-title":"Validation of the Spanish version of the Liverpool Adverse Events Profile in patients with epilepsy","volume":"15","author":"Carre\u00f1o","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eplepsyres.2011.01.008","article-title":"Validation of the Chinese version of the Liverpool Adverse Events Profile in patients with epilepsy","volume":"94","author":"Chen","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1684\/j.1950-6945.2005.tb00110.x","article-title":"Psychometric validation of the French version of the Side Effects and Life Satisfaction inventory (SEALS) in epileptic patients: comparison with the QOLIE-31 inventory and a generic quality of life questionnaire","volume":"7","author":"Hasnaouis","year":"2005","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0080","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/0895-4356(93)90142-N","article-title":"Cross-cultural adaptation of health related quality of life measures: literature review and proposed guidelines","volume":"46","author":"Guillemin","year":"1993","journal-title":"J Clin Epidemiol"},{"issue":"2, Suppl. 1","key":"10.1016\/j.yebeh.2011.08.005_bb0085","first-page":"S86","article-title":"Tradu\u00e7\u00e3o e adapta\u00e7\u00e3o transcultural do \u201cLiverpool Adverse Events Profile\u201d LAEP para o Brasil","volume":"16","author":"Martins","year":"2010","journal-title":"J Epilepsy Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0090","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1212\/01.wnl.0000345667.45642.61","article-title":"Adverse antiepileptic drug effects: toward a clinically and neurobiologically relevant taxonomy","volume":"72","author":"Perucca","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results","volume":"42","author":"Hermann","year":"1997","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1590\/S0034-89101995000500004","article-title":"Transtornos de humor em enfermarias de cl\u00ednica m\u00e9dica e valida\u00e7\u00e3o de escala de medida (HAD) de ansiedade e depress\u00e3o","volume":"29","author":"Botega","year":"1995","journal-title":"Rev Saude Publica"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yebeh.2006.08.022","article-title":"Validity and reliability of the Portuguese version of the Quality of Life in Epilepsy Inventory (QOLIE-31) for Brazil","volume":"10","author":"Da Silva","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1528-1157.1998.tb01278.x","article-title":"Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory","volume":"39","author":"Cramer","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for classification of epilepsies and epileptic syndromes","volume":"30","author":"Commission on Classification and Terminology of the International League Against Epilepsy","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0125","series-title":"Psychometric theory","author":"Nunnally","year":"1994"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0130","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archneur.60.8.1100","article-title":"Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy","volume":"60","author":"Prasad","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0135","series-title":"Applied linear statistical models","author":"Neter","year":"1996"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0140","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0404.1997.tb00106.x","article-title":"Adverse effects in epilepsy therapy. Wait and see or go for it?","volume":"95","author":"Deckers","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0145","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2165\/00003495-198631030-00003","article-title":"Drug treatment of epilepsy: outlines, criticism and perspectives","volume":"31","author":"Beghi","year":"1986","journal-title":"Drugs"},{"issue":"Suppl. 4","key":"10.1016\/j.yebeh.2011.08.005_bb0150","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1111\/j.1528-1167.2005.463010.x","article-title":"Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy","volume":"46","author":"Selai","year":"2005","journal-title":"Epilepsia"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2011.08.005_bb0155","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1212\/WNL.58.8_suppl_5.S27","article-title":"Depression and epilepsy: how closely related are they?","volume":"58","author":"Kanner","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0160","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200519030-00003","article-title":"Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy","volume":"19","author":"Isojarvi","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1528-1167.2010.02520.x","article-title":"Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy","volume":"51","author":"Canevini","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.seizure.2006.02.009","article-title":"A cross-sectional study of subjective complaints in patients with epilepsy who seem to be well-controlled with anti-epileptic drugs","volume":"15","author":"Uijl","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.53.1.162","article-title":"Seizure frequency and the health-related quality of life of adults with epilepsy","volume":"53","author":"Leidy","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.yebeh.2008.12.010","article-title":"Validity and reliability of the Portuguese\u2013Brazilian version of the Quality of Life in Epilepsy Inventory-89","volume":"14","author":"Azevedo","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2011.08.005_bb0190","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1212\/WNL.33.3_Suppl_1.26","article-title":"A method of quantification for the evaluation of antiepileptic drug therapy","volume":"33","author":"Cramer","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0920-1211(02)00182-1","article-title":"Overtreatment in epilepsy: adverse consequences and mechanisms","volume":"52","author":"Perucca","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0200","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00002018-200730070-00001","article-title":"Negative effects of antiepileptic drugs on mood in patients with epilepsy","volume":"30","author":"Mula","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1059-1311(02)00263-7","article-title":"Clobazam monotherapy in drug naive adult patients with epilepsy","volume":"12","author":"Mehndiratta","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2011.08.005_bb0210","first-page":"1","article-title":"Technique for the measurement of attitudes","volume":"140","author":"Likert","year":"1932","journal-title":"Arch Psychol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011004537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011004537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T09:02:03Z","timestamp":1712826123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505011004537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1525505011004537"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2011.08.005","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}